Think of Enterprise Value as the theoretical takeover price. It is more comprehensive than market capitalization (Market Cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.
EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Sequana Medical NV's Enterprise Value is €48.16 Mil.
Sequana Medical NV's EBIT for the trailing twelve months (TTM) ended in Jun. 2023 was €-30.42 Mil. Therefore, Sequana Medical NV's EV-to-EBIT ratio for today is -1.58.
EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA. As of today, Sequana Medical NV's Enterprise Value is €48.16 Mil.
Sequana Medical NV's EBITDA for the trailing twelve months (TTM) ended in Jun. 2023 was €-30.07 Mil. Therefore, Sequana Medical NV's EV-to-EBITDA ratio for today is -1.60.
EV-to-Revenue is calculated as Enterprise Value divided by its Revenue. As of today, Sequana Medical NV's Enterprise Value is €48.16 Mil.
Sequana Medical NV's Revenue for the trailing twelve months (TTM) ended in Jun. 2023 was €0.84 Mil. Therefore, Sequana Medical NV's EV-to-Revenue ratio for today is 57.19.
Sequana Medical NV Enterprise Value Historical Data
The historical data trend for Sequana Medical NV's Enterprise Value can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Sequana Medical NV's Enterprise Value
For the Medical Devices subindustry, Sequana Medical NV's Enterprise Value, along with its competitors' market caps and Enterprise Value data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Sequana Medical NV's Enterprise Value Distribution in the Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Sequana Medical NV's Enterprise Value distribution charts can be found below:
* The bar in red indicates where Sequana Medical NV's Enterprise Value falls into.
Sequana Medical NV Enterprise Value Calculation
Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.
Sequana Medical NV's Enterprise Value for the fiscal year that ended in Dec. 2022 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Sequana Medical NV (STU:2SE) Enterprise Value Explanation
When an investor buy a company, the investor needs to pay not only the common shares, he/she also needs to pay the shareholders of Preferred Stocks. He also assumes the debt of the company, and receives the cash on the company's balance sheet.
If a company has more cash than debt, the investor actually pays less than the Market Cap because he immediately owns the cash once the transaction goes through.
The market value of Preferred Stock needs to be added to the market value of common stocks in the calculation of Enterprise Value.
For the companies with the same Market Cap, the smaller the Enterprise Value is, the cheaper the company is.
Enterprise Value can be negative when the company's net cash is more than its Market Cap. In this case the investor is basically getting the company for free and get paid for that.
1. EV-to-EBIT is calculated as Enterprise Value divided by its EBIT.
Sequana Medical NV's current Enterprise Value is €48.16 Mil.
For company reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data. Sequana Medical NV's EBIT for the trailing twelve months (TTM) ended in Jun. 2023 was €-30.42 Mil.
2. EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA.
Sequana Medical NV's current Enterprise Value is €48.16 Mil.
For company reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data. Sequana Medical NV's EBITDA for the trailing twelve months (TTM) ended in Jun. 2023 was €-30.07 Mil.
Sequana Medical NV's current Enterprise Value is €48.16 Mil.
For company reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data. Sequana Medical NV's Revenue for the trailing twelve months (TTM) ended in Jun. 2023 was €0.84 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Sequana Medical NV Enterprise Value Related Terms
Thank you for viewing the detailed overview of Sequana Medical NV's Enterprise Value provided by GuruFocus.com. Please click on the following links to see related term pages.
Sequana Medical NV is a commercial-stage medical device company focused on the development of treatment solutions for the management of fluid overload in liver disease, malignant ascites, and heart failure. The company's products include an alfa pump, which provides a treatment solution for the long-term management of liver refractory ascites and malignant ascites with safety, efficacy, and quality of life benefits demonstrated in multiple clinical studies and over 750 implants. The company's geographical segments include Switzerland, Germany, the United Kingdom, and the Rest of the world, out of which Germany accounts for the majority of the revenue.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
STU:2SE has been successfully added to your 